Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2005 2
2006 3
2007 5
2008 3
2009 8
2010 6
2011 3
2013 2
2014 5
2015 6
2016 4
2017 4
2018 4
2019 5
2020 7
2021 6
2022 7
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes.
Boughton CK, Allen JM, Ware J, Wilinska ME, Hartnell S, Thankamony A, Randell T, Ghatak A, Besser REJ, Elleri D, Trevelyan N, Campbell FM, Sibayan J, Calhoun P, Bailey R, Dunseath G, Hovorka R; CLOuD Consortium. Boughton CK, et al. Among authors: dunseath g. N Engl J Med. 2022 Sep 8;387(10):882-893. doi: 10.1056/NEJMoa2203496. N Engl J Med. 2022. PMID: 36069870 Clinical Trial.
Stability of proinsulin in whole blood.
Bright DJ, Dunseath GJ, Peter R, Luzio S. Bright DJ, et al. Among authors: dunseath gj. Clin Biochem. 2018 Feb;52:153-155. doi: 10.1016/j.clinbiochem.2017.10.005. Epub 2017 Oct 16. Clin Biochem. 2018. PMID: 29051035 Free article.
GADA testing: the current state of knowledge.
Davies H, Brophy S, Bain SC, Stephens JW, Lewis J, Luzio S, Dunseath G, Beaverstock C, Williams DR. Davies H, et al. Among authors: dunseath g. Prim Care Diabetes. 2009 Aug;3(3):189-91. doi: 10.1016/j.pcd.2009.07.002. Epub 2009 Aug 27. Prim Care Diabetes. 2009. PMID: 19716357 Review.
Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.
Tatovic D, McAteer MA, Barry J, Barrientos A, Rodríguez Terradillos K, Perera I, Kochba E, Levin Y, Dul M, Coulman SA, Birchall JC, von Ruhland C, Howell A, Stenson R, Alhadj Ali M, Luzio SD, Dunseath G, Cheung WY, Holland G, May K, Ingram JR, Chowdhury MMU, Wong FS, Casas R, Dayan C, Ludvigsson J. Tatovic D, et al. Among authors: dunseath g. Immunother Adv. 2022 Jan 27;2(1):ltac002. doi: 10.1093/immadv/ltac002. eCollection 2022. Immunother Adv. 2022. PMID: 35919496 Free PMC article.
75 results